NCT03464604

Melanoma Accuracy Study; Phase 2

Melanoma Accuracy Study, Phase Two

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 121 (actual)
• Sponsor: Nova Scotia Health Authority · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the process, accuracy and patient outcomes of pre-screening dermatology referrals in a clinical setting by a qualified nurse. The long-range goal of the proposed program is to improve referral wait times for patients to see a dermatologist for lesions suspicious for melanoma in comparison to normal standards of care in NS. If effective, this screening program would decrease wait times for those patients with lesions suspicious for melanoma providing earlier diagnosis and expedited treatment, and potentially reducing mortality rates.

Detailed description

The purpose of this study is to evaluate the process, accuracy and patient outcomes of pre-screening dermatology referrals in a clinical setting by a qualified nurse using a dermatoscope, triaging suspicious lesions vs. benign lesions. The long-range goal of the proposed program is to improve referral wait times for patients to see a dermatologist for lesions suspicious for melanoma in comparison to normal standards of care in NS. If effective, this screening program would decrease wait times for those patients with lesions suspicious for melanoma providing earlier diagnosis and expedited treatment, and potentially reducing mortality rates.

Conditions

• Melanoma

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	active	Pre-screening for melanoma by qualified nurse

Timeline

• Start date: 2018-02-28
• Primary completion: 2018-10-10
• Completion: 2018-10-10
• First posted: 2018-03-14
• Last updated: 2022-11-23

Locations

2 sites across 1 country: Canada